PhD, Health Policy and Management
MSPH, Health Policy and Administration
University of North Carolina, Chapel Hill, NC
BSE, Biomedical Engineering (BS Economics)
Duke University, Durham, NC
Michele Wilson, PhD, is a Senior Director of Health economics at RTI-HS. During his tenure at RTI-HS, Dr. Wilson has worked extensively in the development of advanced economic models, such as cost-effectiveness, cost-benefit, cost-utility, and budget-impact models, using Microsoft Excel and Visual Basic for Applications. Other experience at RTI-HS includes conducting detailed literature reviews and supporting the writing and development of abstracts and manuscripts. Dr. Wilson also has experience in health economic research in a government research setting, including econometric analysis. Dr. Wilson's academic experience is grounded in applied health economics and public health policy. Dr. Wilson's experience includes research in therapeutic areas such as bipolar disorder, pain management, diabetes, chronic obstructive pulmonary disease, schizophrenia, stroke, cardiovascular disease, cancer, myelofibrosis, Parkinson's disease, Alzheimer's disease and dementia, and HIV.
Dr. Wilson has coauthored research published in various journals, including Stroke, Managed Care Interface, Review of Economics of the Household, Value in Health, Respiratory Medicine, Journal of Opioid Management, American Journal of Pharmacy Benefit, and Journal of Health and Economic Issues. Dr. Wilson's work has also been presented at numerous conferences, including the International Society for Pharmacoeconomics and Outcomes Research, Chest, the Winter Workshop on Schizophrenia and Bipolar Disorders, the American Academy of Managed Care Pharmacy, the International Stroke Conference, the American Thoracic Society, the World Congress on Parkinson's Disease and Related Disorders, International Congress of Parkinson's Disease and Movement Disorders, and AcademyHealth.